相关实验视频
Updated: Sep 18, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.3K
人类CD36:基因调控,蛋白质功能及其在动脉样硬化病变发生过程中的作用
1Department of Biochemistry, Pomeranian Medical University, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland.
Genes
|June 26, 2025
概括
CD36受体对于清除氧化LDL和脂肪酸至关重要,影响心血管健康. 它在动脉样硬化中的作用凸显了它对潜在治疗策略的重要性.
科学领域:
- 分子生物学分子生物学
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
背景情况:
- CD36的功能是清除器受体,对于清除长链脂肪酸 (LCFA) 和氧化低密度脂蛋白 (ox-LDL) 来说至关重要.
- CD36基因表现出复杂的替代拼接和促进体使用,导致组织间的转录表达变化.
- CD36活性与炎症,血管生成,细胞和能量恒温有关,影响血管和心血管健康.
研究的目的:
- 审查CD36在心血管疾病 (CAD) 发病过程中的多方面的作用.
- 阐明CD36受体活性与动脉样硬化发展之间的关系.
- 突出CD36作为动脉样硬化相关并发症的潜在治疗点.
主要方法:
- 文献综述侧重于CD36基因表达,功能及其在动脉样硬化中的作用.
- 对调节CD36.6的分子机制的分析.
- 检查CD36在脂质代谢和炎症途径中的参与.
主要成果:
- CD36对于去除ox-LDL至关重要,这是动脉样硬化的关键因素.
- CD36的复杂基因调节有助于其在不同组织中的多样性作用.
- 尽管高加索人有罕见的突变,但CD36在牛-LDL吸收中的作用在动脉样硬化发展中很重要.
结论:
- CD36受体活性是动脉样硬化病变的关键决定因素.
- 了解CD36的功能对于开发CAD新型治疗策略至关重要.
- 向CD36可能是一个有希望的方法来管理动脉样硬化及其并发症.
相关概念视频
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Atherosclerosis I: Introduction
93
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
93
Coronary Artery Disease II: Pathophysiology
42
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Cholesterol: Significance and Regulation
698
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
698
Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69

